THZ1 is a potent, cell-permeable, and selective covalent CDK7 inhibitor (IC₅₀ = 3.2 nM) that preferentially diminishes transcription in cancer cells. It displays unprecedented ability to target a remote cysteine residue located outside of the canoni

Numéro d'article : BIOV9544-25

Unité de mesure : 25 MG

1'130.00 CHF 1130.0 CHF 1'130.00 CHF

1'130.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Fabricant : BIOVISION

Numéro du fabricant : 9544-25

Température de stockage : Freezer (-20)

THZ1 is a potent, cell-permeable, and selective covalent CDK7 inhibitor (IC₅₀ = 3.2 nM) that preferentially diminishes transcription in cancer cells. It displays unprecedented ability to target a remote cysteine residue located outside of the canoni

THZ1 is a potent, cell-permeable, and selective covalent CDK7 inhibitor (IC₅₀ = 3.2 nM) that preferentially diminishes transcription in cancer cells. It displays unprecedented ability to target a remote cysteine residue located outside of the canoni

1'130.00 CHF 1130.0 CHF 1'130.00 CHF

1'130.00 CHF

Not Available For Sale